Pavmed Inc (NQ: PAVM )
5.720 USD -0.450 (-7.29%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 22, 2021 Add to My Watchlist
Press releases about Pavmed Inc
ADDING MULTIMEDIA Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer
October 21, 2021
Lucid Diagnostics Announces Pricing of Initial Public Offering
October 13, 2021
PAVmed Acquires EsophaCap Manufacturer CapNostics LLC
October 07, 2021
PAVmed to Host Digital Health Virtual Investor Event
September 30, 2021
PAVmed to Host Digital Health Virtual Investor Event, Veris Health: Bringing Digital Health to Cancer Care.
PAVmed Subsidiary, Lucid Diagnostics, Files Registration Statement for Proposed Initial Public Offering
September 23, 2021
PAVmed subsidiary, Lucid Diagnostics, files registration statement for proposed initial public offering.
PAVmed Subsidiary Veris Health Joins Microsoft for Startups Global Program and Engages Loka as Software Development Partner
September 21, 2021
PAVmed subsidiary Veris Health joins Microsoft for startups global program and engages Loka as software development partner.
PAVmed to Participate in September Investor and MedTech Conferences
September 07, 2021
PAVmed Provides Business Update and Preliminary Second Quarter 2021 Financial Results
August 12, 2021
PAVmed Provides Business Update and Preliminary Second Quarter 2021 Financial Results. Conference call to be held today at 4:30 PM EDT.
PAVmed subsidiary Lucid Diagnostics launches first Lucid test centers. Patients undergoing esophageal precancer testing in Phoenix metro area.
PAVmed's CEO, Lishan Aklog, will present a corporate update at the 41st Annual Canaccord Genuity Growth Conference on August 11, 2021, at 5:00 PM EDT
Global Industry Executive Aster Angagaw Joins PAVmed Subsidiary Lucid Diagnostics’ Board of Directors
August 03, 2021
Prominent global industry executive Aster Angagaw has joined the Board of Directors of PAVmed's subsidiary, Lucid Diagnostics Inc.
CORRECTING and REPLACING PAVmed to Hold Business Update Conference Call on August 12, 2021
August 02, 2021
PAVmed to hold business update conference call on August 12, 2021. Company conference call and webcast at EDT 4:30PM EDT.
Stanley Lapidus, Founder and Former Chairman & CEO of Exact Sciences, Joins PAVmed Subsidiary Lucid Diagnostics as Vice Chairman of its Board of Directors
July 28, 2021
Stanley Lapidus, former Chairman & CEO of Exact Sciences, joins PAVmed subsidiary Lucid Diagnostics as Vice Chairman of its Board of Directors.
PAVmed Subsidiary Lucid Diagnostics Launches Strategic Partnership with Direct-to-Consumer Telemedicine Company UpScriptHealth
July 22, 2021
PAVmed Subsidiary Lucid Diagnostics launches strategic partnership with direct-to-consumer telemedicine company UpScriptHealth.
Tim Baxter, Former CEO of Samsung Electronics North America and Global Technology Industry Leader, Joins PAVmed Board of Directors
June 14, 2021
PAVmed Subsidiary Lucid Diagnostics Completes European CE Mark Certification of its EsoGuard Esophageal DNA Test
June 10, 2021
PAVmed Launches Digital Health Company Veris Health Inc.
June 02, 2021
PAVmed Subsidiary Lucid Diagnostics Receives CE Mark Certification for its EsoCheck® Esophageal Cell Collection Device
May 26, 2021
PAVmed Receives European CE Mark Certification for its CarpX® Minimally Invasive Carpal Tunnel Device
May 25, 2021
Data Presented at Digestive Disease Week 2021 Support Clinical Utility of PAVmed Subsidiary Lucid Diagnostics’ EsoCheck and EsoGuard Technologies
May 24, 2021
PAVmed Subsidiary Lucid Diagnostics Announces Upcoming Presentation at Digestive Disease Week 2021
May 13, 2021
PAVmed Chairman & CEO Lishan Aklog, M.D. named Top 50 Healthcare Technology CEO by Healthcare Technology Report
April 15, 2021